Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P42768: Variant p.Thr45Met

Actin nucleation-promoting factor WAS
Gene: WAS
Feedback?
Variant information Variant position: help 45 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Threonine (T) to Methionine (M) at position 45 (T45M, p.Thr45Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (M) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In WAS and THC1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 45 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 502 The length of the canonical sequence.
Location on the sequence: help TLLQDHENQRLFEMLGRKCL T LATAVVQLYLALPPGAEHWT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         TLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWT

Mouse                         NLLQDHENQRLFELLGRKCWTLATTVVQLYLALPPGAEHWT

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 502 Actin nucleation-promoting factor WAS
Domain 39 – 148 WH1



Literature citations
Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene.
Kwan S.-P.; Hagemann T.L.; Radtke B.E.; Blaese R.M.; Rosen F.S.;
Proc. Natl. Acad. Sci. U.S.A. 92:4706-4710(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS WAS TRP-43; MET-45; LEU-58; LYS-133 AND THR-134; Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.
Remold-O'Donnell E.; Cooley J.; Shcherbina A.; Hagemann T.L.; Kwan S.-P.; Kenney D.M.; Rosen F.S.;
J. Immunol. 158:4021-4025(1997)
Cited for: VARIANTS WAS TRP-43; MET-45; MET-75 AND CYS-86; Mutation analysis of five Japanese families with Wiskott-Aldrich syndrome and determination of the family members' carrier status using three different methods.
Ariga T.; Yamada M.; Sakiyama Y.;
Pediatr. Res. 41:535-540(1997)
Cited for: VARIANTS WAS LYS-31 AND MET-45; Missense C168T in the Wiskott-Aldrich Syndrome protein gene is a common mutation in X-linked thrombocytopenia.
Ho L.L.; Ayling J.; Prosser I.; Kronenberg H.; Iland H.; Joshua D.;
Br. J. Haematol. 112:76-80(2001)
Cited for: VARIANT THC1 MET-45;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.